SCHOENBERG MARK (Chief Medical Officer) sold 6.3% of their position (10K shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $176.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/13/2025ACC: 0001437749-25-026377
Officer· Chief Medical Officer
Since Jan 2019
-10K
Net shares
Net seller
$176.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−10K
Price / share
$17.69
Trade value
$176.90K
% of position
6.3%
8/11/2025
158.23K→148.23K
Total
Net shares
−10K
Net value
-$176.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/11/2025 | S · Sale | −10K | $17.69 | $176.90K | 6.3% | 158.23K | 148.23K |
| Total | −10K | -$176.90K | ||||||
Derivative Transactions0
No derivative transactions reported